Breast cancer research and treatmentAdultFemaleHumansMiddle AgedAntineoplastic Combined Chemotherapy Protocols
Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy.
Phoebe M Hammer, Sheila Enamandram, Debra M Ikeda, Maggie M Lam, Irene L Wapnir, Erin D Chamberlain, Shagufta Shaheen, Jennifer L Caswell-Jin, Haruka Itakura, Gregory R Bean
Published: 202510.1007/s10549-025-07854-9
Abstract
PURPOSE: Small cell neuroendocrine carcinoma (SCNEC) is a very rare, highly aggressive subtype of breast cancer. There are no standard recommendations for the management of mammary SCNEC, and the use and response to neoadjuvant chemotherapy are not w…
Preview only. Read the full abstract at the source